Vivante Health Raises $16M in Series A Funding

Vivante Health, a Houston, MA-based digital solution for digestive health and disease, raised $16m in Series A funding round.

The round was led by 7wireVentures, joined by new investors Human Capital, Intermountain Ventures, SemperVirens, Elements Health Ventures, and Leaps by Bayer and returning investors FCA Venture Partners, NFP Ventures, Lifeforce Capital, and Big Pi Ventures.

The company intends to use the funds to expand operations and its business reach.

Led by Bill Snyder, CEO, Vivante Health is an innovative digital healthcare company providing an all-in-one gut health program, GIThrive, which empowers people—through innovative technology, advanced science, and on-demand human support—to improve digestive health, while lowering their cost of care. 

Since the beginning of 2021, Vivante Health has grown the company’s client base by 400% through the addition of key Fortune 500 clients that join existing clients such as US Foods, Bucknell University, and Marpai. The company’s commercial expansion is bolstered by partnerships with employer healthcare solutions such as Virgin Pulse and Accolade.